BiOWiSH Technologies develops microbial and biologically enhanced fertilizer and crop products based on its HoloGene 3™ technology, including BiOWiSH® Crop Liquid which can be coated onto dry fertilizer or mixed with liquid fertilizer. The company positions its products to optimize yield potential, express plant vigor, and improve soil productivity while offering industry-leading shelf life and low cost to farmers. BiOWiSH works with more than 60 agronomy partners globally across technology validation, regulatory, and commercialization stages. Recent collaboration with SABIC Agri-Nutrients focuses on commercializing SABIC AN Bio-Enhanced Urea powered by BiOWiSH®, a product designed to improve soil productivity and plant vigor across varied climates and crop types. As part of the partnership, BiOWiSH will expand R&D support and advance customizations across SABIC AN high-efficiency fertilizers. The company emphasizes sustainable, scalable agronomic solutions and global commercialization of its bio-enhanced mineral fertilizer offerings. BiOWiSH develops microorganism-based technologies to increase fertilizer efficiency, promote drought resistance in crops, and extend the shelf life of fresh fruit and vegetables. The underlying microbial technology was first discovered in Southeast Asia in 2007 and the company moved into commercialization with a pool-related product launched last year. Its agricultural product suite includes BiOWiSH Crop (a coating for traditional fertilizers), solutions for hydroponics, aquaculture, beef, dairy and pork farming, and a Fruit & Vegetable Wash that lengthens storage life and reduces wash-chemical use. The company emphasizes that its biotech increases the efficiency of existing nutrients rather than supplying bulk micronutrients, aiming to improve soil health and farmer economics. BiOWiSH has been in quasi-stealth mode until this funding and has a diverse shareholder base including a Fortune 500 company, private-equity funds, Saturn Partners, high-net-worth investors and invested staff. The company will use new proceeds to support expansion and commercialization across markets and regulatory regimes; to date it has raised $40 million in total capital.

Total raised

$5M

Funding rounds

2

Latest round

Series B

Latest activity

May 2016